| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $84.7M | +695.1% |
| R&D Expense | $159.2M | +14.8% |
| SG&A Expense | $117.3M | +31.7% |
| Operating Income | -$187.1M | +12.9% |
| Net Income | -$183.1M | +26.8% |
| EPS (Basic) | -$0.74 | +59.8% |
| EPS (Diluted) | -$0.74 | +59.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.6M | -58.0% |
| Short-term Investments | $516.6M | +61.0% |
| Current Assets | $651.3M | +4.0% |
| Total Assets | $937.6M | -16.8% |
| Current Liabilities | $37.0M | -20.8% |
| Total Liabilities | $104.3M | -47.2% |
| Stockholders' Equity | $833.3M | -10.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$169.6M | -34.3% |
| Capital Expenditures | $24.3M | -62.9% |
| Investing Cash Flow | -$11.5M | +90.5% |
| Financing Cash Flow | $10.6M | -97.3% |
| Free Cash Flow | -$193.8M | -1.1% |